Advanced Medical Solutions Group (LON:AMS) Receives “Buy” Rating from Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Advanced Medical Solutions Group (LON:AMS – Get Rating) in a research note released on Wednesday morning, Marketbeat.com reports. They currently have a GBX 310 ($3.78) price objective on the stock.

Advanced Medical Solutions Group Price Performance

AMS stock opened at GBX 226 ($2.75) on Wednesday. Advanced Medical Solutions Group has a 1 year low of GBX 225.50 ($2.75) and a 1 year high of GBX 319.50 ($3.89). The company has a debt-to-equity ratio of 4.28, a quick ratio of 4.58 and a current ratio of 5.65. The stock’s 50 day moving average price is GBX 257.38 and its 200 day moving average price is GBX 261.74. The firm has a market cap of £490.22 million, a P/E ratio of 2,825.00, a PEG ratio of 2.77 and a beta of 0.60.

Advanced Medical Solutions Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, June 9th. Shareholders of record on Thursday, May 18th will be paid a dividend of GBX 1.51 ($0.02) per share. This represents a dividend yield of 0.57%. The ex-dividend date is Thursday, May 18th. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.64. Advanced Medical Solutions Group’s dividend payout ratio is currently 2,500.00%.

About Advanced Medical Solutions Group

(Get Rating)

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.